• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Treatment of imported severe malaria with artesunate instead of quinine - more evidence needed?

Gert van der Hoek

In Memoriam - Editor, Senior Moderator
Treatment of imported severe malaria with artesunate instead of quinine - more evidence needed?

Jakob P Cramer, Rogelio Lopez-Velez, Gerd D Burchard, Martin P Grobusch and Peter J de Vries
.
Malaria Journal 2011, 10:256 doi:10.1186/1475-2875-10-256

Published: 7 September 2011

Abstract (provisional)

Rapid and fast acting anti-malarials are essential to treat severe malaria. Quinine has been the only option for parenteral therapy until recently. While current evidence shows that intravenous artesunate is more effective than quinine in treating severe malaria in endemic countries, some questions remain regarding safety profiles and drug resistance.

For imported severe malaria, additional unanswered questions are related to generalizability of the findings from endemic countries and to legal aspects, as there is no Good Manufacturing Practice-conform drug available yet. Here, the implications of existing evidence for the treatment of imported severe malaria are discussed.

Malariajournal



The complete article is available as a provisional PDF.

.

See also: http://www.flutrackers.com/forum/showthread.php?t=154797

.
 
Back
Top Bottom